MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--PhotoMedex, Inc. (NASDAQ: PHMD) a leader in the development of proprietary excimer laser and fiber optic systems as well as techniques directed toward dermatological applications, today announced the results of a pilot study indicating that the use of the company’s XTRAC Excimer Laser is effective in treating patients with moderate to severe cases of psoriasis. Psoriasis is a non-contagious, common and chronic condition that usually causes patches of itchy, scaly and sometimes inflamed skin. The XTRAC Laser was previously proven to be very effective in patients with mild to moderate cases of psoriasis.
